Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-17
2006-01-17
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S369000, C514S400000, C548S188000, C548S201000, C548S338100
Reexamination Certificate
active
06987120
ABSTRACT:
Compounds of their salts having general formulas (I) and (II) wherein: s=is an integer equal to 1 or 2, preferably s=2; b0=0 or 1; A is the radical of a drug and is such as to meet the pharmacological tests reported in the description, C and C1are two bivalent radicals. The precursors of the radicals B and B1are such as to meet the pharmacological test reported in the description.in-line-formulae description="In-line Formulae" end="lead"?A—(B)b0—C—N(O)s (I)in-line-formulae description="In-line Formulae" end="tail"?
REFERENCES:
patent: 0 012 866 (1980-07-01), None
patent: 0 549 318 (1993-06-01), None
patent: 0 562 497 (1993-09-01), None
patent: 0 578 494 (1994-01-01), None
patent: 5-39261 (1993-02-01), None
patent: WO 94/12463 (1994-06-01), None
patent: WO 95/09831 (1995-04-01), None
patent: WO 95/30641 (1995-11-01), None
patent: WO 98/09948 (1998-03-01), None
patent: WO 98/21193 (1998-05-01), None
patent: WO 98/58910 (1998-12-01), None
McCance & Huether; Pathophysiology: The Biologic Basis for Disease in Adults and Children 1998, pp. 48-54.
McCance & Huether; Pathophysiology: The Biologic Basis for Disease in Adults and Children 1998, pp. 71-77.
McCance & Huether; Pathophysiology: The Biologic Basis for Disease in Adults and Children 1998, p. 1025.
Schwartz; Free Radical Biology & Medicine, vol. 21, No. 5, 1996, pp. 641-649 “Oxidative Stress During Viral Infection: A Review”.
Silverstein et al.; Ann. Intern. Med. 123/4, 1995, pp. 241-249; “Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs”.
Martindale: The Extra Pharmacopoeia; Thirty-first Edition, 1996, p. 73.
Current Medical Diagnosis & Treatment 1998, 37th Edition, pp. 431 and 794.
Utley & Hochstein; Archives of Biochemistry and Biophysics 118, 1967, pp. 29-32 “Effect of Sulfhydryl Reagents on Peroxidation in Microsomes”.
Baylis et al.; J. Clin. Investigation 90, 1992, pp. 278-281; “Chronic Blockade of Nitric Oxide Synthesis in the Rat Produces Systemic Hypertension and Glomerular Damage”.
Nenseter et al.; Atheroscler. Thromb. 15, 1995, pp. 1338-1344; Paracetamol Inhibitis Copper Ion-Induced, Azo Compound-Initiated, and Mononuclear Cell-Mediated Oxidative Modification of LDL.
Green & Wuts; Protective Groups In Organic Synthesis, Second Edition Harward University Press, 1980.
Remington's Pharmaceutical Sciences, Fifteenth Edition Mack Publishing Company, 1975.
Physicians' Desk Refernece, 50th Edition, 1996.
Arent & Fox PLLC
Badio Barbara P.
Nicox S.A.
LandOfFree
Pharmaceutical compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3559783